Covered recipient · General Payments record
SHELLY NAVATO CAPPS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$2,137.34
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $216.40 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $50.04 | 3 |
| Abbott Laboratories | $49.32 | 2 |
| Acerta Pharma LLC | $35.63 | 2 |
| ABBVIE INC. | $34.47 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.21 | 1 |
| Exact Sciences Corporation | $14.66 | 1 |
| Novo Nordisk AS | $14.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.77 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124813021 | CMS |
| Abbott Laboratories | $24.55 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124813023 | CMS |
| ABBVIE INC. | $21.09 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103414265 | CMS |
| ABBVIE INC. | $13.38 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103414267 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104307140 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.44 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105485957 | CMS |
| Exact Sciences Corporation | $14.66 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114537080 | CMS |
| Novo Nordisk Inc | $14.07 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096598336 | CMS |
| PFIZER INC. | $21.64 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441323 | CMS |
| PFIZER INC. | $13.72 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131448833 | CMS |
| PFIZER INC. | $14.68 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131461320 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.21 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153452873 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.